CompareMarketResearchRequest a sample
Home / Healthcare / Autonomous AI Powered Ophthalmology Screening

Healthcare · Market report

Autonomous AI Powered Ophthalmology Screening Market Size, Share and Forecast 2026-2036

The global autonomous AI powered ophthalmology screening market is worth USD 124 mn in 2026 and is forecast to reach USD 547 mn by 2036, growing at a 16.0% CAGR. United States is the largest country market and Diabetic retinopathy is the largest by condition segment.

USD 124 mnMarket size 2026
USD 547 mnForecast 2036
16.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global autonomous AI powered ophthalmology screening market is worth USD 124 mn in 2026 and is forecast to reach USD 547 mn by 2036, growing at a 16.0% CAGR. United States is the largest country market and Diabetic retinopathy is the largest by condition segment.

ScopeSoftware that uses artificial intelligence to screen retinal images for diabetic eye disease and other conditions without a specialist, with its cameras and screening services.
IndustryHealthcare
Value 2025USD 105 mn
Value 2026USD 124 mn
Value 2036USD 547 mn
CAGR 2026-203616.0%
Volume 20268.34 million exams
Volume 203640.7 million exams
Average price 2026USD 14.8 per exam
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Autonomous AI Powered Ophthalmology Screening market size and forecast, 2026-2036

Exhibit 1The global autonomous AI powered ophthalmology screening market is forecast to grow from USD 124 mn in 2026 to USD 547 mn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 16.0%
Autonomous AI Powered Ophthalmology Screening market value, 2025 to 2036Market value by year. 2025: USD 105 mn; 2026: USD 124 mn; 2027: USD 144 mn; 2028: USD 167 mn; 2029: USD 193 mn; 2030: USD 224 mn; 2031: USD 260 mn; 2032: USD 302 mn; 2033: USD 350 mn; 2034: USD 406 mn; 2035: USD 471 mn; 2036: USD 547 mn. Compound annual growth rate 2026 to 2036: 16.0%.2025124 mn2026260 mn2031547 mn203616.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 124 mn
2027USD 144 mn
2028USD 167 mn
2029USD 193 mn
2030USD 224 mn
2031USD 260 mn
2032USD 302 mn
2033USD 350 mn
2034USD 406 mn
2035USD 471 mn
2036USD 547 mn

Autonomous AI Powered Ophthalmology Screening market segmentation

By condition

Exhibit 2Diabetic retinopathy is the largest segment by condition, with 74.0% of 2026 revenueEstimated share of 2026 global revenue, by condition
Autonomous AI Powered Ophthalmology Screening market share by condition, 2026Share of 2026 revenue by condition. Diabetic retinopathy: 74.0%; Glaucoma and macular disease: 16.0%; Cardiovascular risk from retina: 10.0%.Diabetic retinopathy74.0%Glaucoma and macular disease16.0%Cardiovascular risk from retina10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Diabetic retinopathy74.0%59.6%USD 92 mn13.5%
Glaucoma and macular disease16.0%23.3%USD 20 mn20.4%
Cardiovascular risk from retina10.0%17.1%USD 12 mn22.4%

By setting

Exhibit 3Primary care and clinics adds the most revenue by setting, growing from USD 64 mn in 2026 to USD 280 mn by 2036Estimated revenue in USD by setting, 2026 and 2036 forecast
Autonomous AI Powered Ophthalmology Screening market by setting, 2026 and 2036Revenue by setting in 2026 and 2036. Primary care and clinics: USD 64 mn in 2026, USD 280 mn in 2036, change +335%; Pharmacies and screening programmes: USD 32 mn in 2026, USD 166 mn in 2036, change +417%; Hospital eye departments: USD 27 mn in 2026, USD 100 mn in 2036, change +266%.20262036 forecastChangePrimary care and clinics+335%64 mn280 mnPharmacies and screening programmes+417%32 mn166 mnHospital eye departments+266%27 mn100 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Primary care and clinics52.0%51.3%USD 64 mn15.8%
Pharmacies and screening programmes26.0%30.4%USD 32 mn17.8%
Hospital eye departments22.0%18.2%USD 27 mn13.8%

By device format

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Desktop fundus cameras40.0%34.0%USD 50 mn14.1%
Handheld cameras26.0%28.0%USD 32 mn16.9%
Smartphone attachments14.0%18.0%USD 17 mn18.9%
OCT based systems20.0%20.0%USD 25 mn16.0%

By business model

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Per scan fee42.0%42.0%USD 52 mn16.0%
Software licence30.0%28.0%USD 37 mn15.2%
Hardware bundle28.0%30.0%USD 35 mn16.8%

By patient group

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Diabetic patients58.0%54.0%USD 72 mn15.2%
Older adults24.0%25.0%USD 30 mn16.5%
Premature infants8.0%9.0%USD 9.9 mn17.4%
General population10.0%12.0%USD 12 mn18.1%

Top 25 countries for autonomous AI powered ophthalmology screening by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 93.0% of 2026 revenue and the 25 countries below together hold 98.5%.

Exhibit 4United States is the largest country market at USD 50 mn in 2026, and the three largest countries hold 61.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Autonomous AI Powered Ophthalmology Screening market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 50 mn, 40.0%; India: USD 17 mn, 14.0%; Singapore: USD 8.7 mn, 7.0%; United Kingdom: USD 7.4 mn, 6.0%; China: USD 7.4 mn, 6.0%; Thailand: USD 6.2 mn, 5.0%; Brazil: USD 5.6 mn, 4.5%; Australia: USD 5.0 mn, 4.0%; Netherlands: USD 4.3 mn, 3.5%; Saudi Arabia: USD 3.7 mn, 3.0%.United States50 mn 40.0%India17 mn 14.0%Singapore8.7 mn 7.0%United Kingdom7.4 mn 6.0%China7.4 mn 6.0%Thailand6.2 mn 5.0%Brazil5.6 mn 4.5%Australia5.0 mn 4.0%Netherlands4.3 mn 3.5%Saudi Arabia3.7 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 50 mn40.0%USD 181 mn13.9%
2IndiaUSD 17 mn14.0%USD 115 mn20.8%
3SingaporeUSD 8.7 mn7.0%USD 32 mn13.8%
4United KingdomUSD 7.4 mn6.0%USD 30 mn14.8%
5ChinaUSD 7.4 mn6.0%USD 49 mn20.8%
6ThailandUSD 6.2 mn5.0%USD 25 mn14.8%
7BrazilUSD 5.6 mn4.5%USD 26 mn16.8%
8AustraliaUSD 5.0 mn4.0%USD 18 mn13.8%
9NetherlandsUSD 4.3 mn3.5%USD 16 mn13.8%
10Saudi ArabiaUSD 3.7 mn3.0%USD 21 mn18.8%
11SpainUSD 1.2 mn1.0%USD 4.6 mn14.1%
12MexicoUSD 0.89 mn0.7%USD 3.8 mn15.5%
13CanadaUSD 0.82 mn0.7%USD 3.1 mn14.3%
14MalaysiaUSD 0.76 mn0.6%USD 3.2 mn15.4%
15IndonesiaUSD 0.64 mn0.5%USD 2.7 mn15.3%
16VietnamUSD 0.47 mn0.4%USD 2.0 mn15.4%
17IsraelUSD 0.36 mn0.3%USD 1.4 mn14.3%
18KenyaUSD 0.36 mn0.3%USD 1.5 mn15.6%
19United Arab EmiratesUSD 0.28 mn0.2%USD 1.2 mn15.5%
20PhilippinesUSD 0.26 mn0.2%USD 1.1 mn15.4%
21SwitzerlandUSD 0.21 mn0.2%USD 0.77 mn13.8%
22SwedenUSD 0.19 mn0.1%USD 0.71 mn14.3%
23BelgiumUSD 0.15 mn0.1%USD 0.55 mn13.9%
24DenmarkUSD 0.14 mn0.1%USD 0.49 mn13.7%
25AustriaUSD 0.11 mn0.09%USD 0.38 mn13.1%
Rest of worldUSD 1.8 mn1.5%USD 7.0 mn14.6%
Exhibit 5United States and India account for 54% of the USD 423 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Autonomous AI Powered Ophthalmology Screening market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 124 mn. United States: +USD 132 mn; India: +USD 97 mn; China: +USD 42 mn; Singapore: +USD 23 mn; United Kingdom: +USD 22 mn; 20 other countries: +USD 101 mn; Rest of world: +USD 5.2 mn. Market value 2036: USD 547 mn.Market value 2026124 mnUnited States+132 mnIndia+97 mnChina+42 mnSingapore+23 mnUnited Kingdom+22 mn20 other countries+101 mnRest of world+5.2 mnMarket value 2036547 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Digital Diagnostics
  • Eyenuk
  • Optomed
  • Topcon Healthcare

Group 2: Regional and specialist players

  • Eyris
  • AEYE Health
  • Retmarker
  • Remidio Innovative Solutions
  • Airdoc
  • Optos
  • Medios Technologies

Group 3: Emerging and niche players

  • RetinAI
  • Retinalyze
  • Notal Vision

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the autonomous AI powered ophthalmology screening market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 16.0% is calculated from the resulting values.

The market is divided by condition, by setting, by device format, by business model, by patient group. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the autonomous AI powered ophthalmology screening market?

The global autonomous AI powered ophthalmology screening market is estimated at USD 105 mn in 2025 and USD 124 mn in 2026.

How fast will the autonomous AI powered ophthalmology screening market grow?

It is forecast to reach USD 547 mn by 2036, a compound annual growth rate of 16.0% from 2026, an increase of USD 423 mn.

Which country is the largest market for autonomous AI powered ophthalmology screening?

United States is the largest market by revenue at USD 50 mn in 2026, 40.0% of the global total. The three largest countries together hold 61.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 20.8% a year from 2026 to 2036.

Which autonomous AI powered ophthalmology screening segment is largest?

In the by condition split, Diabetic retinopathy is the largest segment with 74.0% of 2026 revenue.

Who are the leading autonomous AI powered ophthalmology screening companies?

Global leaders include Digital Diagnostics, Eyenuk, Optomed, Topcon Healthcare.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Automated CPR Device Behavioral Health Care Coordination →

All Healthcare markets →

Request a sample